Davis R M Inc
- SEC CIK
- 0000891287
- Latest filing
- Aug 14, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Davis R M Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 18,009
- Value
- $4.53M
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 18,009 | $4.53M | 0.1% | +109+0.6% | Added | Holders |
| Q1 2026 | 17,900 | $3.89M | 0.1% | +875+5.1% | Added | Holders |
| Q4 2025 | 17,025 | $3.89M | 0.1% | +1,494+9.6% | Added | Holders |
| Q3 2025 | 15,531 | $3.60M | 0.1% | −1,129−6.8% | Reduced | Holders |
| Q2 2025 | 16,660 | $3.09M | 0.1% | −3,978−19.3% | Reduced | Holders |
| Q1 2025 | 20,638 | $4.32M | 0.1% | +3,178+18.2% | Added | Holders |
| Q4 2024 | 17,460 | $3.10M | 0.1% | −1,833−9.5% | Reduced | Holders |
| Q3 2024 | 19,293 | $3.81M | 0.1% | −121−0.6% | Reduced | Holders |
| Q2 2024 | 19,414 | $3.33M | 0.1% | +53+0.3% | Added | Holders |
| Q1 2024 | 19,361 | $3.53M | 0.1% | −594−3.0% | Reduced | Holders |
| Q4 2023 | 19,955 | $3.09M | 0.1% | −1,588−7.4% | Reduced | Holders |
| Q3 2023 | 21,543 | $3.21M | 0.1% | −1,516−6.6% | Reduced | Holders |
| Q2 2023 | 23,059 | $3.11M | 0.1% | +840+3.8% | Added | Holders |
| Q1 2023 | 22,219 | $3.54M | 0.1% | −1,237−5.3% | Reduced | Holders |
| Q4 2022 | 23,456 | $3.79M | 0.1% | −150−0.6% | Reduced | Holders |
| Q3 2022 | 23,606 | $3.17M | 0.1% | −1,563−6.2% | Reduced | Holders |
| Q2 2022 | 25,169 | $3.85M | 0.1% | +546+2.2% | Added | Holders |
| Q1 2022 | 24,623 | $3.99M | 0.1% | +3,691+17.6% | Added | Holders |
| Q4 2021 | 20,932 | $2.83M | 0.1% | −60−0.3% | Reduced | Holders |
| Q3 2021 | 20,992 | $2.26M | 0.1% | −329−1.5% | Reduced | Holders |
| Q2 2021 | 21,321 | $2.40M | 0.1% | +669+3.2% | Added | Holders |
| Q1 2021 | 20,652 | $2.23M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.